T1	Participants 67 93	middle-aged men and women.
T2	Participants 386 412	middle-aged men and women.
T3	Participants 420 569	Men and women aged 40-65 y (n = 38) underwent a double-blind, randomized, placebo-controlled, crossover trial of treatment with 0.7 g DHA/d for 3 mo.
T4	Participants 1295 1321	middle-aged men and women.
